Apac Biotech Pvt. Ltd., of Gurgaon, India, signed a technology transfer and licensing agreement with Diakonos Research Ltd., of Houston, to test an immunotherapy that targets and activates the tumor antigen-specific CTL response in phase II trials in India for advanced brain and pancreatic cancers. Terms of the deal weren't disclosed.